FOXA1 and breast cancer: In line with these findings, a study by Badve and colleagues [38] performed on 404 patients with BC demonstrated that FOXA1 expression tested on tissue microarray correlates significantly with ER (p = 0.000001), PR (p = 0.00001), and luminal subtype A (p = 0.000001).